Aurélie Sadoux

460 total citations
30 papers, 287 citations indexed

About

Aurélie Sadoux is a scholar working on Molecular Biology, Oncology and Dermatology. According to data from OpenAlex, Aurélie Sadoux has authored 30 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Dermatology. Recurrent topics in Aurélie Sadoux's work include Melanoma and MAPK Pathways (9 papers), Cell Adhesion Molecules Research (6 papers) and Histiocytic Disorders and Treatments (5 papers). Aurélie Sadoux is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), Cell Adhesion Molecules Research (6 papers) and Histiocytic Disorders and Treatments (5 papers). Aurélie Sadoux collaborates with scholars based in France, United States and Spain. Aurélie Sadoux's co-authors include Samia Mourah, Célèste Lebbé, Maxime Battistella, Marie-Pierre Podgorniak, Suzanne Ménashi, Fanélie Jouenne, Anne Janin, Baptiste Louveau, Niclas Setterblad and Nicolas Dumaz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aurélie Sadoux

27 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurélie Sadoux France 11 157 119 81 40 39 30 287
Katherine Shi United States 9 164 1.0× 195 1.6× 43 0.5× 51 1.3× 65 1.7× 12 324
Johanne Lade‐Keller Denmark 8 169 1.1× 193 1.6× 63 0.8× 18 0.5× 15 0.4× 17 304
Huayang Tang China 9 97 0.6× 24 0.2× 120 1.5× 28 0.7× 34 0.9× 25 266
Benjamin Weide Germany 13 246 1.6× 328 2.8× 164 2.0× 18 0.5× 33 0.8× 25 488
Janice M. Mehnert United States 8 303 1.9× 183 1.5× 52 0.6× 17 0.4× 12 0.3× 24 409
Burkhard Bueltmann Germany 6 121 0.8× 252 2.1× 74 0.9× 26 0.7× 47 1.2× 10 318
Philip Eliades United States 9 193 1.2× 245 2.1× 121 1.5× 8 0.2× 67 1.7× 12 481
Hiroyuki Sonegawa Japan 8 306 1.9× 35 0.3× 115 1.4× 23 0.6× 24 0.6× 9 394
Joanna Poźniak Belgium 10 235 1.5× 154 1.3× 118 1.5× 8 0.2× 15 0.4× 18 406
Qinyuan Liao China 10 166 1.1× 74 0.6× 171 2.1× 13 0.3× 6 0.2× 19 326

Countries citing papers authored by Aurélie Sadoux

Since Specialization
Citations

This map shows the geographic impact of Aurélie Sadoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Sadoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Sadoux more than expected).

Fields of papers citing papers by Aurélie Sadoux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Sadoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Sadoux. The network helps show where Aurélie Sadoux may publish in the future.

Co-authorship network of co-authors of Aurélie Sadoux

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Sadoux. A scholar is included among the top collaborators of Aurélie Sadoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Sadoux. Aurélie Sadoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benhamouda, Nadine, Lucie Biard, Laetitia Da Meda, et al.. (2025). Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma. EMBO Molecular Medicine. 17(5). 909–922. 2 indexed citations
2.
Louveau, Baptiste, Fanélie Jouenne, Barouyr Baroudjian, et al.. (2024). Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets. SHILAP Revista de lepidopterología. 2. 100206–100206. 1 indexed citations
3.
Louveau, Baptiste, Fanélie Jouenne, Paul Vilquin, et al.. (2024). Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1. Oncogene. 43(21). 1620–1630. 5 indexed citations
4.
Louveau, Baptiste, Fanélie Jouenne, Aurélie Sadoux, et al.. (2023). Combined PDE4+MEK inhibition shows antiproliferative effects in NRAS Q61 mutated melanoma preclinical models. Melanoma Research. 34(2). 186–192. 1 indexed citations
5.
Villoutreix, Bruno O., Maxime Battistella, Aurélie Sadoux, et al.. (2022). Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction. Oncogene. 41(15). 2254–2264. 7 indexed citations
6.
Masson, Adèle de, Constance de Margerie‐Mellon, É. de Kerviler, et al.. (2021). Image‐guided lymph node core‐needle biopsy predicts survival in mycosis fungoides and Sézary syndrome*. British Journal of Dermatology. 185(2). 419–427. 6 indexed citations
7.
Wang, Jingying, Adèle de Masson, C. Ram‐Wolff, et al.. (2021). Granulomatous rash associated with mogamulizumab mimicking mycosis fungoides: a case series. European Journal of Cancer. 156. S49–S49. 2 indexed citations
8.
Masson, Adèle de, Gábor Dobos, Marie Boisson, et al.. (2021). Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients. Blood. 139(12). 1820–1832. 41 indexed citations
9.
Louveau, Baptiste, Fanélie Jouenne, Aurélie Sadoux, et al.. (2020). A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping. Targeted Oncology. 15(6). 759–771. 5 indexed citations
10.
Jouenne, Fanélie, Aurélie Sadoux, Gwenaël Lorillon, et al.. (2020). Custom pyrosequencing assay to detect short BRAF deletions in Langerhans cell histiocytic lesions. Journal of Clinical Pathology. 74(8). 533–536. 1 indexed citations
11.
Jouenne, Fanélie, Jérôme Le Goff, Emmanuelle Bugnet, et al.. (2020). Lack of evidence for the involvement of Merkel cell polyomavirus in pulmonary Langerhans cell histiocytosis. ERJ Open Research. 6(2). 230–2019.
12.
Vercellino, Laëtitia, Fanélie Jouenne, Barouyr Baroudjian, et al.. (2019). Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma. Translational Oncology. 13(2). 275–286. 13 indexed citations
13.
Jouenne, Fanélie, Sylvie Chevret, Emmanuelle Bugnet, et al.. (2019). Genetic landscape of adult Langerhans cell histiocytosis with lung involvement. European Respiratory Journal. 55(2). 1901190–1901190. 32 indexed citations
14.
Tazi, Abdellatif, Fanélie Jouenne, Emmanuelle Bugnet, et al.. (2019). Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis. OA2141–OA2141.
15.
Louveau, Baptiste, Jörg Tost, Florence Mauger, et al.. (2017). Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor. ESMO Open. 2(2). e000173–e000173. 6 indexed citations
16.
Delyon, Julie, Mariana Varna, Jean‐Paul Feugeas, et al.. (2016). Validation of a preclinical model for assessment of drug efficacy in melanoma. Oncotarget. 7(11). 13069–13081. 10 indexed citations
17.
Battistella, Maxime, Jean‐Paul Feugeas, Cécile Pagès, et al.. (2016). EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma. Experimental Dermatology. 25(8). 618–622. 16 indexed citations
18.
Lebbé, Célèste, Alexandre How‐Kit, Aurélie Sadoux, et al.. (2014). BRAFV600 mutation levels and response to vemurafenib in metastatic melanoma.. Journal of Clinical Oncology. 32(15_suppl). 9005–9005. 1 indexed citations
19.
Lebbé, Célèste, Alexandre How‐Kit, Maxime Battistella, et al.. (2014). BRAF V600 mutation levels predict response to vemurafenib in metastatic melanoma. Melanoma Research. 24(4). 415–418. 18 indexed citations
20.
Dumaz, Nicolas, et al.. (2014). Driver KIT mutations in melanoma cluster in four hotspots. Melanoma Research. 25(1). 88–90. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine Shi Breakdown of academic impact, for papers by Johanne Lade‐Keller Breakdown of academic impact, for papers by Huayang Tang Breakdown of academic impact, for papers by Benjamin Weide Breakdown of academic impact, for papers by Janice M. Mehnert Breakdown of academic impact, for papers by Burkhard Bueltmann Breakdown of academic impact, for papers by Philip Eliades Breakdown of academic impact, for papers by Hiroyuki Sonegawa Breakdown of academic impact, for papers by Joanna Poźniak Breakdown of academic impact, for papers by Qinyuan Liao
Rankless by CCL
2026